Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence

This is a prospective, open-label therapeutic interventional investigation designed to interrogate the efficacy and safety of individualized matched therapies in patients with pancreatic cancer at high risk of disease recurrence post-surgery.

Trial Details

NCT ID
NCT06228599
Phase
NA
Sponsor
Medical College of Wisconsin
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • Treatment Plan
Locations (sample)
  • Milwaukee, Wisconsin, United States|43.0389,-87.90647

Key Eligibility Criteria

  • Age ≥18 years.
  • Pathologically confirmed pancreatic cancer (excluding neuroendocrine histology).
  • Pancreatic tumor is surgically removed and
  • patient has received multimodal therapy (neoadjuvant, sandwich or adjuvant chemotherapy ± radiation) or

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →